GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » T2 Biosystems Inc (FRA:3T2) » Definitions » Cyclically Adjusted PB Ratio

T2 Biosystems (FRA:3T2) Cyclically Adjusted PB Ratio : 0.03 (As of Jun. 09, 2024)


View and export this data going back to 2014. Start your Free Trial

What is T2 Biosystems Cyclically Adjusted PB Ratio?

As of today (2024-06-09), T2 Biosystems's current share price is €4.06. T2 Biosystems's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was €120.05. T2 Biosystems's Cyclically Adjusted PB Ratio for today is 0.03.

The historical rank and industry rank for T2 Biosystems's Cyclically Adjusted PB Ratio or its related term are showing as below:

FRA:3T2' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 0.11   Med: 2.31   Max: 22.99
Current: 0.19

During the past years, T2 Biosystems's highest Cyclically Adjusted PB Ratio was 22.99. The lowest was 0.11. And the median was 2.31.

FRA:3T2's Cyclically Adjusted PB Ratio is ranked better than
88.97% of 136 companies
in the Medical Diagnostics & Research industry
Industry Median: 2.01 vs FRA:3T2: 0.19

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

T2 Biosystems's adjusted book value per share data for the three months ended in Mar. 2024 was €-6.304. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €120.05 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


T2 Biosystems Cyclically Adjusted PB Ratio Historical Data

The historical data trend for T2 Biosystems's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

T2 Biosystems Cyclically Adjusted PB Ratio Chart

T2 Biosystems Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - 12.00 0.25

T2 Biosystems Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.72 1.47 4.79 0.25 0.13

Competitive Comparison of T2 Biosystems's Cyclically Adjusted PB Ratio

For the Diagnostics & Research subindustry, T2 Biosystems's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


T2 Biosystems's Cyclically Adjusted PB Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, T2 Biosystems's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where T2 Biosystems's Cyclically Adjusted PB Ratio falls into.



T2 Biosystems Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

T2 Biosystems's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=4.06/120.05
=0.03

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

T2 Biosystems's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, T2 Biosystems's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book=Book Value per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-6.304/131.7762*131.7762
=-6.304

Current CPI (Mar. 2024) = 131.7762.

T2 Biosystems Quarterly Data

Book Value per Share CPI Adj_Book
201406 -436.894 100.560 -572.519
201409 237.862 100.428 312.110
201412 214.470 99.070 285.274
201503 198.901 99.621 263.101
201506 149.362 100.684 195.487
201509 104.307 100.392 136.916
201512 178.242 99.792 235.369
201603 129.762 100.470 170.195
201606 82.770 101.688 107.260
201609 148.102 101.861 191.598
201612 122.337 101.863 158.263
201703 79.552 102.862 101.914
201706 35.655 103.349 45.462
201709 42.488 104.136 53.766
201712 3.149 104.011 3.990
201803 -22.712 105.290 -28.425
201806 62.976 106.317 78.057
201809 46.241 106.507 57.212
201812 22.658 105.998 28.168
201903 -3.153 107.251 -3.874
201906 -31.040 108.070 -37.849
201909 -50.404 108.329 -61.313
201912 -60.422 108.420 -73.438
202003 -5.845 108.902 -7.073
202006 -3.034 108.767 -3.676
202009 10.084 109.815 12.101
202012 4.844 109.897 5.808
202103 -0.320 111.754 -0.377
202106 4.511 114.631 5.186
202109 -1.262 115.734 -1.437
202112 -6.862 117.630 -7.687
202203 -13.588 121.301 -14.761
202206 -17.885 125.017 -18.852
202209 -9.073 125.227 -9.548
202212 -485.148 125.222 -510.542
202303 -228.761 127.348 -236.716
202306 -13.900 128.729 -14.229
202309 -4.600 129.860 -4.668
202312 -6.335 129.419 -6.450
202403 -6.304 131.776 -6.304

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


T2 Biosystems  (FRA:3T2) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


T2 Biosystems Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of T2 Biosystems's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


T2 Biosystems (FRA:3T2) Business Description

Traded in Other Exchanges
Address
101 Hartwell Avenue, Lexington, MA, USA, 02421
T2 Biosystems Inc provides rapid in vitro diagnostic tests to hospitals and laboratories. The company's core technology is T2 Magnetic Resonance (T2MR) technology, which can detect a variety of molecular targets directly from whole blood. T2MR technology enables the T2Dx system, which is fully automated from patient sample to result for its panels focused on bacterial and fungal infections that could cause sepsis, and its pipeline panel for Lyme disease.

T2 Biosystems (FRA:3T2) Headlines

No Headlines